Related references
Note: Only part of the references are listed.Airway Fibroblasts in Asthma Manifest an Invasive Phenotype
Jennifer L. Ingram et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma
Prescott G. Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
Shironjit K. Saha et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
Can guideline-defined asthma control be achieved? The gaining optimal asthma control study
ED Bateman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Significant variability in response to inhaled corticosteroids for persistent asthma
SJ Szefler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Advances in immunology - Asthma
WW Busse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
